Kidswell Bio Overview
- Year Founded
-
2001
- Status
-
Public
- Employees
-
42
- Stock Symbol
-
4584
- Investments
-
4
- Share Price
-
$0.85
- (As of Tuesday Closing)
Kidswell Bio General Information
Description
Kidswell Bio Corp is a biopharmaceutical company engaged in the discovery and development of drugs.
Contact Information
Website
www.kidswellbio.comCorporate Office
- 3rd Floor, Kanayama Building
- 1-2-12, Shinkawa
- Tokyo, Chuo-ku
- Japan
Corporate Office
- 3rd Floor, Kanayama Building
- 1-2-12, Shinkawa
- Tokyo, Chuo-ku
- Japan
Kidswell Bio Stock Performance
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.85 | $0.84 | $0.60 - $1.61 | $33.6M | 39.4M | 675K | -$0.28 |
Kidswell Bio Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2024 | FY 2024 31-Mar-2024 | FY 2023 31-Mar-2023 | FY 2022 31-Mar-2022 |
|---|---|---|---|---|
| EV | 38,934 | 38,934 | 65,975 | 113,670 |
| Revenue | 16,826 | 16,826 | 20,507 | 13,968 |
| EBITDA | (9,557) | (9,557) | (4,583) | (4,743) |
| Net Income | (9,842) | (9,842) | (4,856) | (4,903) |
| Total Assets | 33,601 | 33,601 | 29,230 | 28,434 |
| Total Debt | 17,014 | 17,014 | 14,635 | 5,735 |
Kidswell Bio Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kidswell Bio Patents
Kidswell Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-WO2019216438-A1 | Periodontal disease therapeutic agent containing culture supernatant of mesenchymal cells | Pending | 11-May-2018 | ||
| JP-WO2019054460-A1 | Anti-ramp2 antibody | Active | 13-Sep-2017 | 0 | |
| JP-2022169737-A | Anti-ramp2 antibody | Pending | 13-Sep-2017 | 0 | |
| CA-3075867-A1 | Anti-ramp2 antibody | Inactive | 13-Sep-2017 | ||
| US-20200270579-A1 | Method for preparing dental pulp stem cells from cells derived from dental pulp tissue | Inactive | 03-Feb-2017 | C12N5/0664 |
Kidswell Bio Executive Team (5)
| Name | Title | Board Seat |
|---|---|---|
| Masaharu Tani | President & Chief Executive Officer | |
| Masanari Kawaminami | President & Board Member | |
| Yasuo Sakae | Chief Financial Officer | |
| Masayuki Kawakami | Chief Operating Officer, Corporate Officer & Chief Technology Officer | |
| Yoshikazu Amano | Fellow , Research & Development and Business Development |
Kidswell Bio Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Masanari Kawaminami | Kidswell Bio | President & Board Member | 000 0000 |
Kidswell Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Kidswell Bio Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Kidswell Bio Investments & Acquisitions (4)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Heartseed | 11-Mar-2020 | 00000 0000 | 000.00 | Drug Discovery | |
| Advanced Cell Technology and Engineering | 17-Jan-2019 | 0000000000 | Other Healthcare Services | ||
| Advanced Cell Technology and Engineering | 30-Mar-2018 | 00000 0000 | Other Healthcare Services | ||
| OrthoReBirth | 27-Nov-2014 | Seed Round | 00.00 | Other Devices and Supplies | 00000000 |
Kidswell Bio ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Kidswell Bio Exits (3)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Heartseed | 11-Mar-2020 | 00000 00000 | 000.00 | Completed |
|
| Advanced Cell Technology and Engineering | 17-Jan-2019 | 000000000000 | Completed |
|
|
| Advanced Cell Technology and Engineering | 30-Mar-2018 | Later Stage VC | Completed |
|
Kidswell Bio FAQs
-
When was Kidswell Bio founded?
Kidswell Bio was founded in 2001.
-
Who is the CEO of Kidswell Bio?
Masaharu Tani is the CEO of Kidswell Bio.
-
Where is Kidswell Bio headquartered?
Kidswell Bio is headquartered in Tokyo, Japan.
-
What is the size of Kidswell Bio?
Kidswell Bio has 42 total employees.
-
What industry is Kidswell Bio in?
Kidswell Bio’s primary industry is Biotechnology.
-
Is Kidswell Bio a private or public company?
Kidswell Bio is a Public company.
-
What is Kidswell Bio’s stock symbol?
The ticker symbol for Kidswell Bio is 4584.
-
What is the current stock price of Kidswell Bio?
As of 10-Sep-2024 the stock price of Kidswell Bio is $0.85.
-
What is the current market cap of Kidswell Bio?
The current market capitalization of Kidswell Bio is $33.6M.
-
What is Kidswell Bio’s current revenue?
The trailing twelve month revenue for Kidswell Bio is $16.8M.
-
What is Kidswell Bio’s annual earnings per share (EPS)?
Kidswell Bio’s EPS for 12 months was -$0.28.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
